The private label CBD gummies market is poised for significant expansion, with a projected compound annual growth rate (CAGR) of 7.9% from 2026 to 2036, according to a report by Future Market Insights (FMI). The market, valued at $598.9 million in 2025, is expected to reach $646.2 million in 2026 and grow to $1,382.2 million by 2036. This growth is driven by wellness brands increasingly adopting outsourced manufacturing to reduce capital investment and accelerate product launches.
White label gummies dominate the service model segment, accounting for 46.2% of global demand in 2026. Their popularity stems from shorter commercialization timelines, lower formulation costs, and established manufacturing processes, enabling new brands to enter the market quickly. Broad-spectrum CBD gummies lead the spectrum demand with a 42.8% market share, driven by consumer preference for THC-free products that retain multiple cannabinoids. Brand websites are the leading sales channel, capturing 39.6% of global demand, as they provide greater control over customer education, subscription programs, and compliance updates.
The United States is the fastest-growing market, with a CAGR of 8.5% through 2036, supported by a strong direct-to-consumer infrastructure and a mature CBD ecosystem. Canada, the United Kingdom, Germany, and Australia are also key growth markets, with CAGRs of 8.1%, 7.8%, 7.5%, and 7.3%, respectively. Regulatory complexity remains a challenge, as differences in CBD regulations across countries can delay commercialization and increase compliance costs.
Key players in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., CV Sciences, Inc., Medterra CBD LLC, British Cannabis, Cannaray Limited, MediPharm Labs Corp., and Little Green Pharma Ltd. These companies compete on formulation expertise, manufacturing scalability, and compliance support. As the market evolves, competitive advantage will depend on suppliers that combine formulation expertise with comprehensive testing and compliant labeling, enabling brands to scale confidently.
For detailed market forecasts and competitive benchmarking, access the full report at Future Market Insights. The report provides insights into service models, CBD spectrum, dosage strength, sales channels, buyer types, and regions.
The growth of the private label CBD gummies market reflects broader trends in the wellness industry, where brands prioritize speed to market and cost efficiency. Direct-to-consumer sales through brand websites are transforming how CBD products reach consumers, offering greater transparency and educational opportunities. As regulatory frameworks become clearer, particularly in Europe and Australia, the market is expected to see continued expansion. The emphasis on third-party testing and batch traceability will likely become a standard requirement, further shaping industry dynamics.
